Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients

Koldo García‐Etxebarria(Karolinska Institutet), Mauro D’Amato(Ikerbasque), Peter T. Schmidt(Uppsala University), Ferdinando Bonfiglio(Ceinge Biotecnologie Avanzate (Italy)), Greger Lindberg(Karolinska Institutet), Massimo Bellini(University of Pisa), William D. Chey(University of Michigan–Ann Arbor), Bodil Ohlsson(Skåne University Hospital), Giovanni Barbara(University of Bologna), Rosario Cuomo(Federico II University Hospital), Emeran A. Mayer(University of California, Los Angeles), Mira M. Wouters(KU Leuven), Pontus Karling(Umeå University), Lin Chang(University of California, Los Angeles), Tenghao Zheng(Monash University), Guy E. Boeckxstaens(KU Leuven), Daisy Jonkers(Maastricht University), Matteo Neri(University of Chieti-Pescara), Purna Kashyap(Mayo Clinic), André Franke(Christian-Albrechts-Universität zu Kiel), Gerardo Nardone(Federico II University Hospital), Aldona Dlugosz(Karolinska University Hospital), Luís Bujanda(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Francesca Galeazzi, Magnus Simrén(Sahlgrenska University Hospital), Paolo Usai–Satta, Piero Portincasa(University of Bari Aldo Moro), Susanna Walter(Linköping University), Shanti Eswaran(Kenya Institute for Public Policy Research and Analysis), Michael Camilleri(CSIRO Manufacturing)
Clinical Gastroenterology and Hepatology
February 21, 2018
Cited by 95


Related Papers